Tag: Biotech and Pharmaceuticals
Browse our exclusive articles!
Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar
Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by $3 billion as sales...
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
President Joe Biden speaks during an event at the National Institutes of Health in Bethesda, Maryland, Dec. 14, 2023.
Chris Kleponis | Bloomberg | Getty...
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.
Brendan McDermid | Reuters
All doses...
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024.
Shelby Knowles |...
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021.
Dado Ruvic | Reuters
Biogen on Thursday...